LCTX vs VRTX: Which Stock is Better?
Side-by-side comparison of Lineage Cell Therapeutics Inc and Vertex Pharmaceuticals Inc in 2026
LCTX
Lineage Cell Therapeutics Inc
$1.71
VRTX
Vertex Pharmaceuticals Inc
$441.20
Key Metrics Comparison
| Metric | LCTX | VRTX | Winner |
|---|---|---|---|
| Market Cap | $408.50M | $110.81B | VRTX |
| P/E Ratio | N/A | 28.42 | VRTX |
| EPS (TTM) | $N/A | $15.33 | VRTX |
| Revenue Growth | 1.3% | 0.1% | LCTX |
| Gross Margin | -22.8% | 53.7% | VRTX |
Analyze LCTX
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is LCTX or VRTX a better investment?
Comparing LCTX and VRTX: Lineage Cell Therapeutics Inc has a market cap of $408.50M while Vertex Pharmaceuticals Inc has $110.81B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between LCTX and VRTX?
LCTX (Lineage Cell Therapeutics Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: LCTX or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: LCTX or VRTX?
LCTX has higher revenue growth at 1.3% vs 0.1% for VRTX.
Which company is more profitable: LCTX or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to -22.8% for LCTX.
Which is the larger company: LCTX or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $110.81B compared to $408.50M for LCTX.
Should I buy LCTX or VRTX in 2026?
Both LCTX and VRTX have investment merit. LCTX trades at $1.71 while VRTX trades at $441.20. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between LCTX and VRTX stock?
Key differences: Market Cap ($408.50M vs $110.81B), P/E Ratio (N/A vs 28.4x), Revenue Growth (1.3% vs 0.1%), Gross Margin (-22.8% vs 53.7%).